For short-life ATMPs, sterility is assured throughout the entire manufacturing process, not by a sin...
Insights
Rethinking CAR-T Manufacturing: A Single-Step Path to Lower COGS and Higher Yield Autologous CAR-T t...
Designing an operational model for autologous T cell manufacturing is only the starting point. Execu...
From process design to patient delivery, success depends on how the manufacturing system operates un...
From activation through gene modification and expansion, small development decisions often determine...
The decision to build in-house or partner with a CDMO is less philosophical than it appears. At its ...
Cell therapy involves the transfer of living cells into a patient to treat, cure, or prevent disease...
When mesenchymal stem cells (MSCs) behave, they are remarkably manufacturable. When they do not, the...
MSC manufacturing appears straightforward on paper: initiate, expand, harvest, formulate, cryopreser...
Navigating the Cell Therapy Manufacturing Landscape The journey from scientific discovery to clinica...